Biotech | January 10, 2022
Bayer and Mammoth Biosciences to collaborate on gene editing technology
Under the terms of the agreement, Mammoth Biosciences will receive an upfront payment of USD 40 million, potential future payments of more than one billion USD upon successful achievement of certain research, development, and commercial milestones
